GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a prominent focus in medical investigation, largely due to its notable impact on controlling conditions such as adult-onset diabetes and obesity. New trials have demonstrated that in addition to glucose control, GLP-1 drugs offer benefits for heart function and perhaps n